I am responsible for fostering and maintaining strategic scientific partnerships with global organisations, with the overall goal of addressing relevant public health challenges. My research interest is in understanding the genomic epidemiology of bacterial and viral infections that are prevalent in low- and middle-income countries, as well as building genomic surveillance capacity globally.

I have previously held the position of Senior Bioinformatician at the Wellcome Sanger Institute where led the planning, development, and delivery of our advanced bioinformatics training for our global projects, which were delivered in three continents to 150 participants from low- and middle-income countries (LMICs). I completed my DPhil and Postdoc from the University of Oxford. My DPhil project focused on tackling hepatitis B virus elimination and specifically addressing the question of drug and vaccine resistance. I have worked on projects on Yellow Fever, SARs-CoV-2, Dengue and Chikungunya viruses, and neurological disorders. I have served as a consultant to World Health Organisation (WHO) on a project addressing the public health importance of Parkinson’s disease and I was invited to take a leadership role and presented at the WHO expert meeting on integrated global action plan on drug resistance for HIV and viral hepatitis, in Geneva in July 2023. I have also served as an Advisor to the Movement Disorders Society.